Hospital-Level Compliance With Asthma Care Quality Measures at Children's Hospitals and Subsequent Asthma-Related Outcomes

PEDIATRICS ◽  
2012 ◽  
Vol 130 (Supplement) ◽  
pp. S36-S36
Author(s):  
N. Raje ◽  
C. Dinakar
JAMA ◽  
2011 ◽  
Vol 306 (13) ◽  
pp. 1454 ◽  
Author(s):  
Rustin B. Morse ◽  
Matthew Hall ◽  
Evan S. Fieldston ◽  
Gerd McGwire ◽  
Melanie Anspacher ◽  
...  

Author(s):  
Kathleen Chiotos ◽  
Lauren D’Arinzo ◽  
Eimear Kitt ◽  
Rachael Ross ◽  
Jeffrey S. Gerber

OBJECTIVES Empirical broad-spectrum antibiotics are routinely administered for short durations to children with suspected bacteremia while awaiting blood culture results. Our aim for this study was to estimate the proportion of broad-spectrum antibiotic use accounted for by these “rule-outs.” METHODS The Pediatric Health Information System was used to identify children aged 3 months to 20 years hospitalized between July 2016 and June 2017 who received broad-spectrum antibiotics for suspected bacteremia. Using an electronic definition for a rule-out, we estimated the proportion of all broad-spectrum antibiotic days of therapy accounted for by this indication. Clinical and demographic characteristics, as well as antibiotic choice, are reported descriptively. RESULTS A total of 67 032 episodes of suspected bacteremia across 42 hospitals were identified. From these, 34 909 (52%) patients were classified as having received an antibiotic treatment course, and 32 123 patients (48%) underwent an antibiotic rule-out without a subsequent treatment course. Antibiotics prescribed for rule-outs accounted for 12% of all broad-spectrum antibiotic days of therapy. Third-generation cephalosporins and vancomycin were the most commonly prescribed antibiotics, and substantial hospital-level variation in vancomycin use was identified (range: 16%–58% of suspected bacteremia episodes). CONCLUSIONS Broad-spectrum intravenous antibiotic use for rule-out infections appears common across children’s hospitals, with substantial hospital-level variation in the use of vancomycin in particular. Antibiotic stewardship programs focused on intervening on antibiotics prescribed for longer durations may consider this novel opportunity to further standardize antibiotic regimens and reduce antibiotic exposure.


CHEST Journal ◽  
2009 ◽  
Vol 135 (5) ◽  
pp. 1193-1196 ◽  
Author(s):  
Mihail Samnaliev ◽  
Jeffrey D. Baxter ◽  
Robin E. Clark

2016 ◽  
Vol 11 (5) ◽  
pp. 317-323 ◽  
Author(s):  
Kavita Parikh ◽  
Matt Hall ◽  
Anne J. Blaschke ◽  
Carlos G. Grijalva ◽  
Thomas V. Brogan ◽  
...  

2016 ◽  
Vol 38 (4) ◽  
pp. 243-253
Author(s):  
Anupama Subramony ◽  
Matthew Hall ◽  
Cherie Thomas ◽  
Vincent W. Chiang ◽  
Richard E. McClead ◽  
...  

PEDIATRICS ◽  
2012 ◽  
Vol 130 (3) ◽  
pp. 482-491 ◽  
Author(s):  
B. A. Fassl ◽  
F. L. Nkoy ◽  
B. L. Stone ◽  
R. Srivastava ◽  
T. D. Simon ◽  
...  

Author(s):  
Yao Tian ◽  
Matt Hall ◽  
Martha-Conley E Ingram ◽  
Andrew Hu ◽  
Mehul V Raval

BACKGROUND: Observation status could improve efficiency of healthcare resource use but also might shift financial burdens to patients and hospitals. Although the use of observation stays has increased for adult patient populations, the trends are unknown among hospitalized children. OBJECTIVE: The goal of this study was to describe recent trends in observation stays for pediatric populations at children’s hospitals. DESIGN, SETTING, AND PARTICIPANTS: Both observation and inpatient stays for all conditions were retrospectively studied using the Pediatric Health Information System database (2010 to 2019). EXPOSURE, MAIN OUTCOMES, AND MEASURES: Patient type was classified as inpatient or observation status. Main outcomes included annual percentage of observation stays, annual percentage of observation stays having prolonged length of stay (>2 days), and growth rates of observation stays for the 20 most common conditions. Risk adjusted hospital-level use of observation stays was estimated using generalized linear mixed-effects models. RESULTS: The percentage of observation stays increased from 23.6% in 2010 to 34.3% in 2019 (P < .001), and the percentage of observation stays with prolonged length of stay rose from 1.1% to 4.6% (P < .001). Observation status was expanded among a diverse group of clinical conditions; diabetes mellitus and surgical procedures showed the highest growth rates. Adjusted hospital-level use ranged from 0% to 67% in 2019, indicating considerable variation among hospitals. CONCLUSION: Based on the increase in observation stays, future studies should explore the appropriateness of observation care related to efficient use of healthcare resources and financial implications for hospitals and patients.


Sign in / Sign up

Export Citation Format

Share Document